Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 19, 2022
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
[ Mon, Dec 19th 2022
] - WOPRAI
Constantine Davides Initiated (ACST) at Strong Buy and Held Target at $15 on, Dec 19th, 2022
Constantine Davides of EF Hutton, Initiated "Acasti Pharma Inc." (ACST) at Strong Buy and Held Target at $15 on, Dec 19th, 2022.
Constantine has made no other calls on ACST in the last 4 months.
There is 1 other peer that has a rating on ACST. Out of the 1 peers that are also analyzing ACST, 0 agree with Constantine's Rating of Hold.
This is the rating of the analyst that currently disagrees with Constantine
- Oren Livnat of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $14 on, Thursday, December 15th, 2022
